NOTE: This Discussion is closed.
DISCUSSION: Prioritization in the Health Care and Community Support Services (HC/CSS) Group
Discussion List > Discussion: Prioritization in the Health Care and Community Support Services (HC/CSS) Group > Comment
COMMENT: Tests to document immunity from infection or vaccine
Submitted by Brant Goode
on 12/5/07 8:33 AM
This is a great discussion thread. We don't yet have tests approved for an event that hasn't yet occurred--they'll be developed rapidly but the demand for testing will almost certainly outstrip capacity--sound familiar?
Nonetheless, identifying those who are protected either from infection or vaccination will not likely occur as quickly or easily as it might. The use of antivirals is currently focusing on treatment vs prevention, although increased stocks will allow some targeted preventive treatment.
We can predict--with degrees of uncertainty--that a vaccine may have similar efficacy as seasonal flu vaccine. That said, we will have to measure such efficacy during the actual event.
Finally, re the need to slow the pandemic before we have a vaccine that does work: this is where non-pharmacologic interventions (NPIs) have deep value.
COMMENT THREAD
VIEW: Outline Full Text COMMENT ORDER: Newest First Oldest First
Submitted by Caroline Bridgers on 12/5/07 07:07 AM
-
Health Care personnel exposure, why vaccinate those who've recovered?
Submitted by Brant Goode
on 12/5/07 07:18 AM
-
doesn't make sense to use antivirals for weeks as preventative
Submitted by Caroline Bridgers on 12/5/07 07:38 AM
-
OSHA can't figure this out for for personal protective equipment
Submitted by Nick Kelley on 12/5/07 09:02 AM
-
-
A high attack rate/ case fatality rate scenario
Submitted by Catherine Jackie Mitchell on 12/5/07 10:25 AM
-
-
-
-
-
Won't we have tests to determine who has been infected?
Submitted by Caroline Bridgers on 12/5/07 07:59 AM
-
Tests to document immunity from infection or vaccine
Submitted by Brant Goode
on 12/5/07 08:33 AM
-
-
HCWs acquiring and treated for influenza during pandemic.
Submitted by Mona Wenger on 12/5/07 09:03 AM
-
recovered individuals in the most exposure-heavy positions
Submitted by Antanina Perricone on 12/6/07 10:34 AM
-
-
-
-
-
-
How does this immunity affect the prioritization proposed in the Guidance?
Submitted by Nicholas Dewar
on 12/5/07 10:13 AM
-
-
-
Include a small percentage of Non-Clinical hospital workers in Tier 1
Submitted by Susan Webb on 12/5/07 12:43 PM
-
-
-
How does this immunity affect the prioritization proposed in the
Submitted by Glenda Ford-Lee on 12/6/07 06:44 AM
-
-
How long is someone protected from subsequent infections with mutated strains?
Submitted by Brant Goode
on 12/5/07 10:38 AM
-
protection against mutated strains--need to revax front line workers?
Submitted by Brant Goode
on 12/5/07 10:20 AM
-
can we predict whether vaccine would be effective in 2nd and subsequent waves of a pandemic?
Submitted by Victoria Davey
on 12/5/07 10:26 AM
-
-
-
What if anti-virals are not provided or not effective to treat strain?
Submitted by Debra Mattas on 12/5/07 08:13 AM
-
What if anti-virals are not provided or not effective to treat strain?
Submitted by Eleanor Peters
on 12/5/07 08:30 AM
-
I was not suggesting exclusing health care workers
Submitted by Caroline Bridgers on 12/5/07 10:11 AM
-
Can you frame comments in this thread as proposals for changes to the Guidance?
Submitted by Nicholas Dewar
on 12/5/07 10:17 AM
-
-
-
So how would you change the prioritization to handle this?
Submitted by Nicholas Dewar
on 12/5/07 12:36 PM
-
General Population involved in mitigation
Submitted by Catherine Jackie Mitchell on 12/5/07 02:39 PM
-
-
-